Human biomonitoring and chemical exposure assessment
21 European H2020 organizations list this as part of their work — 14 as their primary capability.
Most active in this area
- SCIENSANO
Belgium's national public health institute specializing in vaccine quality, genomic diagnostics, health data infrastructure, and One Health research across 53 countries.
“HBM4EU on chemical mixture exposure biomarkers, Imptox on microplastics toxicity, and ALTERNATIVE on chemical mixture effects on cardiac tissue.”
BE25 projects - UMWELTBUNDESAMT
Germany's Federal Environment Agency — regulatory science authority for chemical safety, human biomonitoring, and environmental health policy across Europe.
“Coordinated HBM4EU (€11M, the flagship EU biomonitoring initiative), and participated in ERGO, PlasticsFatE, POLYRISK, and ZeroPM — all focused on exposure, hazard, and health effects of chemicals.”
PrimaryDE16 projects - INSTITUTO NACIONAL DE SAUDE DR. RICARDO JORGE
Portugal's national public health institute specializing in epidemiological surveillance, human biomonitoring, food safety, and health data infrastructure across European networks.
“Major role in HBM4EU (EUR 1M+ funding) tracking population exposure to endocrine disruptors and chemical mixtures.”
PrimaryPT13 projects - NACIONALNI INSTITUT ZA JAVNO ZDRAVJE
Slovenia's national public health institute specializing in human biomonitoring, population health data infrastructure, and evidence-based health policy across Europe.
“HBM4EU (their largest project at EUR 247K), EuroMix (chemical mixtures risk), and Equal-Life (exposome and environmental quality) all center on measuring and interpreting human exposure to chemicals.”
PrimarySI12 projects - LIETUVOS SVEIKATOS MOKSLU UNIVERSITETAS
Lithuanian medical-veterinary university contributing to European epidemiological surveillance, human biomonitoring, animal production research, and integrated mental health care.
“HBM4EU (as third party) involved them in European biomonitoring of endocrine disruptors, chemical mixtures, and establishing reference values.”
LT9 projects - NEMZETI NEPEGESZSEGUGYI ES GYOGYSZERESZETI KOZPONT
Hungary's national public health and pharmacy authority, contributing epidemiological data, biomonitoring, and regulatory expertise to pan-European health research networks.
“HBM4EU (EUR 151K) focused on exposure biomarkers, endocrine disruptors, chemical mixtures, and establishing reference values across European cohorts.”
PrimaryHU9 projects - AGENCE NATIONALE DE SANTE PUBLIQUE
France's national public health agency contributing epidemiological surveillance, biomonitoring data, and population health expertise to European research consortia.
“Participated in HBM4EU, the flagship European biomonitoring initiative covering exposure biomarkers, endocrine disruptors, and chemical mixtures in human populations.”
PrimaryFR7 projects - YPOURGEIO YGEIAS
Cyprus national health authority contributing population biomonitoring data, chemical exposure assessment, and food safety expertise to pan-European research consortia.
“HBM4EU (their largest project at EUR 478K) and EuroMix both focus on monitoring population exposure to chemical mixtures and endocrine disruptors.”
PrimaryCY7 projects - INSTYTUT MEDYCYNY PRACY IMIENIA PROF. DRA MED. JERZEGO NOFERA W LODZI
Polish occupational medicine institute specializing in chemical biomonitoring, alternative toxicity testing, and workplace mental health research.
“Core contributor to HBM4EU (the EU's flagship biomonitoring initiative), EXPANSE (urban exposome), and MEDIRAD (radiation exposure).”
PrimaryPL7 projects - ISTITUTO UNIVERSITARIO DI STUDI SUPERIORI ( I.U.S.S.) DI PAVIA
Italian graduate school specializing in human biomonitoring, exposome science, and environmental risk assessment across health and natural hazards.
“Central to both HBM4EU (European biomonitoring initiative) and NEUROSOME (neurological exposome), covering exposure biomarkers, endocrine disruptors, and chemical mixtures.”
PrimaryIT5 projects - HRVATSKI ZAVOD ZA JAVNO ZDRAVSTVO
Croatia's national public health institute contributing population health data, biomonitoring, and epidemiological expertise to pan-European health research consortia.
“HBM4EU — contributed to the European Human Biomonitoring Initiative tracking population exposure to endocrine disruptors and chemical mixtures.”
PrimaryHR5 projects - USTAV EXPERIMENTALNI MEDICINY AKADEMIE VED CESKE REPUBLIKY VEREJNA VYZKUMNA INSTITUCE
Czech Academy institute building 3D tissue models and nanofiber scaffolds for drug testing, toxicology screening, and regenerative medicine.
“Contributed to HBM4EU as a third party, working on exposure biomarkers, endocrine disruptors, and chemical mixture reference values across European cohorts.”
CZ5 projects - J.Z.U. INSTITUT ZA JAVNO ZDRAVJE NA REPUBLIKA SEVERNA MAKEDONIJA SKOPJE
North Macedonia's national public health institute, contributing population biomonitoring data, environmental health epidemiology, and food safety metrology to pan-European research consortia.
“HBM4EU focused on exposure and effect biomarkers, chemical mixtures, and reference values; Equal-Life extended this to exposome research in early childhood.”
PrimaryMK5 projects - NATURVARDSVERKET
Sweden's national environmental authority contributing regulatory expertise, biodiversity data, and policy translation to European ecosystem and biomonitoring research.
“Received their largest single grant (EUR 763,809) through HBM4EU, contributing national data on chemical mixtures, endocrine disruptors, and health survey cohorts.”
SE5 projects - UMIT TIROL - PRIVATE UNIVERSITAT FUR GESUNDHEITSWISSENSCHAFTEN UND TECHNOLOGIE GMBH
Austrian private health sciences university contributing epidemiology, biomonitoring, medical device regulation, and nature-based health intervention expertise to EU consortia.
“Contributed to HBM4EU as a third party, working on exposure biomarkers, effect biomarkers, chemical mixtures, and establishing HBM reference values across European populations.”
AT5 projects - INSTITUT ZA MEDICINSKA ISTRAZIVANJA I MEDICINU RADA
Croatian research institute specializing in human biomonitoring, chemical risk assessment, and nanotechnology safety governance.
“Core contributor to HBM4EU (Europe's flagship biomonitoring initiative) and involved in radiation protection research via CONCERT.”
PrimaryHR4 projects - STATNI ZDRAVOTNI USTAV
Czech national public health institute contributing food safety surveillance, human biomonitoring, and One Health expertise to pan-European health programmes.
“HBM4EU focused on exposure biomarkers, endocrine disruptors, and reference values; EuroMix addressed chemical mixture risk assessment.”
PrimaryCZ4 projects - UNIVERZITA KONSTANTINA FILOZOFA VNITRE
Slovak university contributing regional expertise in public health biomonitoring, cultural tourism research, and biodiversity-transport integration across large EU consortia.
“Contributed to HBM4EU as a third party, working on exposure biomarkers, endocrine disruptors, and health survey data across European cohorts.”
SK3 projects - LABORATOIRE NATIONAL DE SANTE
Luxembourg's national health reference lab specializing in population-level chemical exposure biomonitoring, HBM reference values, and emerging microbiome standards.
“LNS participated in HBM4EU (2017-2022), the flagship pan-European human biomonitoring initiative, covering exposure biomarkers, effect biomarkers, endocrine disruptors, and chemical mixture reference values.”
PrimaryLU2 projects - INSTITUTO POLITECNICO DE LISBOA
Portuguese polytechnic with specialist expertise in sickle cell disease epidemiology and European human biomonitoring, with active African research connections.
“IPL contributed as a third party in HBM4EU (2017-2022), the European Human Biomonitoring Initiative covering exposure biomarkers, endocrine disruptors, chemical mixtures, and HBM reference values across 26+ countries.”
PT2 projects - SLOVENSKA ZDRAVOTNICKA UNIVERZITA V BRATISLAVE
Slovak Medical University specializing in human biomonitoring, chemical exposure assessment, and molecular defense mechanisms in mammals.
“SZU participated in HBM4EU (2017–2022), the flagship European human biomonitoring initiative, contributing to exposure biomarker measurement, HBM reference values, and policy translation for endocrine disruptors and chemical mixtures.”
PrimarySK2 projects